Glenmark Pharmaceutical Inc recalls ranitidine tablets in US
Posted by
www.biotecnika.org
The tablets are being recalled because of the presence or potential
presence of N-nitrosodimethylamine (NDMA) levels above the acceptable
daily intake levels established by the United States Food and Drug
Administration (USFDA), as per the company's announcement posted on
the website of the US health regulator.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharmaceutical-inc-recalls-ranitidine-tablets-in-us/articleshow/72922629.cms
Subscribe to:
Post Comments (Atom)
Post a Comment